Cargando…

Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

Detalles Bibliográficos
Autores principales:	Anderson, Tara C., Masters, Nina B., Guo, Angela, Shepersky, Leah, Leidner, Andrew J., Lee, Grace M., Kotton, Camille N., Dooling, Kathleen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2022
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774159/ https://www.ncbi.nlm.nih.gov/pubmed/35051134 http://dx.doi.org/10.15585/mmwr.mm7103a2

Ejemplares similares

Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
por: Krow-Lucal, Elisabeth, et al.
Publicado: (2022)

Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
por: Dooling, Kathleen L., et al.
Publicado: (2018)

Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022
por: Collins, Jennifer P., et al.
Publicado: (2022)

The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021
por: Mbaeyi, Sarah, et al.
Publicado: (2021)

Updated Framework for Development of Evidence-Based Recommendations by the Advisory Committee on Immunization Practices
por: Lee, Grace, et al.
Publicado: (2018)

Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
por: Melgar, Michael, et al.
Publicado: (2023)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020
por: Dooling, Kathleen, et al.
Publicado: (2020)

The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine — United States, December 2020
por: Dooling, Kathleen, et al.
Publicado: (2021)

Projected risks and health benefits of vaccination against herpes zoster and related complications in US adults
por: Janusz, Cara B., et al.
Publicado: (2022)

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
por: Matanock, Almea, et al.
Publicado: (2019)

1629. Herpes Zoster Risk in Immunocompromised Adults in the United States: A Systematic Review
por: Dooling, Kathleen L, et al.
Publicado: (2019)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020
por: Oliver, Sara E., et al.
Publicado: (2021)

4. Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Adults
por: Dagnew, Alemnew F, et al.
Publicado: (2020)

Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine
por: Wong, Karen K., et al.
Publicado: (2017)

Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices
por: Hills, Susan L., et al.
Publicado: (2019)

Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023
por: Kobayashi, Miwako, et al.
Publicado: (2023)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021
por: Oliver, Sara E., et al.
Publicado: (2021)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2022
por: Murthy, Neil, et al.
Publicado: (2022)

Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
por: Kobayashi, Miwako, et al.
Publicado: (2022)

Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022
por: Twentyman, Evelyn, et al.
Publicado: (2022)

Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
por: Kobayashi, Miwako, et al.
Publicado: (2022)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
por: Oliver, Sara E., et al.
Publicado: (2020)

The Laboratory Advisory Committee
Publicado: (1968)

Inaugural meeting of the malaria policy advisory committee to the WHO: conclusions and recommendations
Publicado: (2012)

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2022
por: Wodi, A. Patricia, et al.
Publicado: (2022)

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022–23 Influenza Season
por: Grohskopf, Lisa A., et al.
Publicado: (2022)

Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
por: Jones, Jefferson M., et al.
Publicado: (2023)

Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022
por: Rosenblum, Hannah G., et al.
Publicado: (2022)

20. Cost-Effectiveness of Recombinant Zoster Vaccine for Vaccinating Immunocompromised Adults Against Herpes Zoster in the United States
por: Curran, Desmond, et al.
Publicado: (2021)

Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer
por: Curran, Desmond, et al.
Publicado: (2023)

Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies
por: Mwakingwe-Omari, Agnes, et al.
Publicado: (2023)

Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting
Publicado: (2012)

Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2013 meeting
Publicado: (2013)

Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2013 meeting
Publicado: (2013)

Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale
por: Rubin, Lorry, et al.
Publicado: (2013)

Advancing human health risk assessment: Integrating recent advisory committee recommendations
por: Dourson, Michael, et al.
Publicado: (2013)

Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020
por: Mbaeyi, Sarah A., et al.
Publicado: (2020)

Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices
por: Meites, Elissa, et al.
Publicado: (2019)

Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
por: Paz-Bailey, Gabriela, et al.
Publicado: (2021)

Leicester Health Advisory Committee
Publicado: (1918)

Cannot write session to /tmp/vufind_sessions/sess_7i2hn1k52grha337lh7ij9iii0